Download PDF
Zeitschrift für Orthomolekulare Medizin 2020; 18(04): 25-32
DOI: 10.1055/a-1305-4284
Wissen

Erschöpfung in der Gynäkologie: Inflammation, Hormone oder Tumor?

Alfred S. Wolf
› Further Information
    Permissions and Reprints

Zusammenfassung

Ein Großteil der an SARS-CoV2-Erkrankten zeigt langzeitige Nebenwirkungen in Form von Erschöpfung, Leistungsverlust und anhaltender Müdigkeit. Generell lassen sich die Ursachen einer Fatigue im Wesentlichen einem Tumor, einer neuroendokrinen Reaktion oder einer Inflammation zuordnen. Der Verlauf und die Klinik der Post-COVID-19-Fatigue ähnelt den Erschöpfungskrankheiten ausgelöst durch Herpesviren. Bei der Therapie spielen Beratung und Coaching eine wichtige Rolle. Zunächst werden verhaltenstherapeutische Maßnahmen geraten, ergänzt durch eine Lebensstilberatung.

Schlüsselwörter:

Erschöpfung - Leistungsverlust - Fatigue - COVID 19 - tumorassoziierte Fatigue - neuroendokrin verursachte Fatigue - chronische Inflammation - Post-COVID-19-Fatigue


Publication History

Article published online:
03 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Tansey CM, Louie M, Loeb M. et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med 2007; 167: 1312-1320
    CrossrefPubMedGoogle Scholar
  • 2 Lam MH-B, Wing Y-K, Wai-Mam M. et al. Mental morbidity and chronic fatigue in severe acute respiratory syndrome survivors. Arch Intern Med 2009; 169: 2142-2147
    CrossrefPubMedGoogle Scholar
  • 3 The Body Politic COVID-19. Group. 2020 https://www.wearebodypolitic.com/covid19
    PubMedGoogle Scholar
  • 4 Tenforde MW, Kim SS, Lindsell CJ. et al. Symptom duration and risk factors for delayed return to usual health among patients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020. MMWR Report 2020 69: 993-8
    Google Scholar
  • 5 Carfi A, Bernabei R, Landi F. et al. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603-605
    CrossrefPubMedGoogle Scholar
  • 6 Calabrese C. Vortrag GSAAM Jahrestagung. , München, Mai: 2018
    Google Scholar
  • 7 Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications. Brain Behav Immun 2013; 30: 48-57
    CrossrefPubMedGoogle Scholar
  • 8 Hickok JT, Roscoe JA, Morrow GR. et al. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 2005; 104: 1772-1778
    CrossrefPubMedGoogle Scholar
  • 9 Horneber M, Fischer I, Dimeo F. et al. Tumor-assoziierte Fatigue. Epidemiologie, Pathogenese, Diagnostik und Therapie. Dtsch Ärztebl 2012; 109: 161-172
    Google Scholar
  • 10 Inagaki M, Yoshikawa E, Matsuoka Y. et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007; 109: 146-156
    CrossrefPubMedGoogle Scholar
  • 11 Fagundes CP, Bennett JM, Derry HM. et al. Relationship and inflammation across the lifespan: Social developmental pathways to disease. Soc Personal Psychol Compass 2011; 5: 891-903
    CrossrefPubMedGoogle Scholar
  • 12 Shumilov A, Tsai MH, Schlosser YT. et al. Epstein-Barr virus particles include centrosome amplification and chromosomal instability. Nature Communications 2017; DOI: 10.1038/ncomms14257.
    CrossrefPubMedGoogle Scholar
  • 13 Crosswell AD, Lockwood KG, Ganz PA. et al. Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinol 2014; 45: 58-66
    CrossrefPubMedGoogle Scholar
  • 14 Burisch M. Das Burnout-Syndrom. 3. Aufl Heidelberg: Springer; 2010
    CrossrefGoogle Scholar
  • 15 Korczak D, Kister C, Huber B. Differentialdiagnose des Burnout-Syndroms. Schriftenreihe Health Technology Assessment (HTA) in der BRD. DIMDI Deutsches Institut für Dokumentation und Information: 2010
    Google Scholar
  • 16 Siegrist J, Starke D, Chandola T. et al. The measurement of effort-reward imbalance at work: European comparisons. Social Science & Medicine 2004; 58: 1483-1499
    CrossrefPubMedGoogle Scholar
  • 17 Siegrist J. Arbeitswelt und stressbedingte Erkrankungen. Forschungsevidenz und präventive Maßnahmen. München: Urban & Fischer; 2015
    Google Scholar
  • 18 Rasa S, Nora-Knukle Z, Henning N. et al. Chronic viral infections in myalgic encephalomyelitis / chronic fatigue syndrome (ME / CFS). Transl Med 2018; 16: 268
    CrossrefPubMedGoogle Scholar
  • 19 Gräfe K, Zipfel S, Herzog W. et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Ergebnisse der deutschen Validierungsstudie. Diagnostica 2004; 50: 171-180
    CrossrefGoogle Scholar
  • 20 Scheibenbogen C, Wittke K, Hanitsch L. et al. Chronisches Fatigue Syndrom. Ärzteblatt Sachsen 2019; 9: 26-30
    Google Scholar
  • 21 Müller K. Stressregulation und Mitochondrienfunktion. Zs f Orthomol Med 2013; 1: 9-13
    Google Scholar
  • 22 Pall ML. Explaining „unexplained illnesses“. New York, London: Informa healthcare; 2009
    PubMedGoogle Scholar
  • 23 Maes M, Twisk FNM. Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine 2010; 8: 35
    CrossrefPubMedGoogle Scholar
  • 24 Schultheiß C, Paschold L, Simnica D. et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity 2020; 53: 442-455
    CrossrefPubMedGoogle Scholar
  • 25 Islam MF, Cotler J, Jason LA. et al. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior; 2020. DOI: 10.1080/21641846.2020.1778227
    CrossrefGoogle Scholar
  • 26 Perrin R, Riste L, Hann M. et al. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses 2020; 144: 110055
    CrossrefPubMedGoogle Scholar
  • 27 Clayton EW. Beyond EM / CFS. An IOM Report on Redefining an Illness. JAMA 2015; 313: 1101-1102
    CrossrefPubMedGoogle Scholar
  • 28 Whooley MA, Avins AL, Miranda J. et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439-445
    CrossrefPubMedGoogle Scholar
  • 29 Carruthers BM, Jain AK, De Meirleir KL. et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrom: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J Chron Fatigue Syndrome 2003; 11: 7-115
    CrossrefGoogle Scholar
  • 30 Carruthers BM, van de Sande MI, de Meirleir KL. et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270: 327-338
    CrossrefPubMedGoogle Scholar
  • 31 Wolf A, Calabrese P. , Hrsg. Stressmedizin & Stresspsychologie. Stuttgart: Schattauer; 2020
    Google Scholar
  • 32 Coy S. Persönliche Mitteilung. 2014
    PubMedGoogle Scholar
  • 33 Kuklinski B. Zur Praxisrelevanz von nitrosativem Stress. umg 2005; 18: 95-105
    Google Scholar
  • 34 Yang T, Yang Y, Wang D. et al. The clinical value of cytokines in chronic fatigue syndroem. J Tranl Med 2019; 17: 213-225
    CrossrefPubMedGoogle Scholar
  • 35 Bierhaus A, Humpert PM, Nawroth PP. NF-kB as a molecular link between psychosocial stress and organ dysfunction. Pediatr Nephrol 2004; 19: 1189-91
    CrossrefPubMedGoogle Scholar